Log In
BCIQ
Print this Print this
 

CL-H1T

  Manage Alerts
Collapse Summary General Information
Company Charleston Laboratories Inc.
DescriptionFixed dose formulation of sumatriptan combined with promethazine
Molecular Target Serotonin (5-HT) receptor ; Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist; Serotonin (5-HT) receptor agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today